K56-2 LPS mutant [ 31, 32] host ranges were performed similarly using wildtype K56-2, RSF19 (wbxE::pRF201), XOA7 (waaL::pGP ΩTp), XOA15 (wabR::pGP ΩTp), XOA17 (wabS::pGPApTp), XOA8 (wabO::pGP ΩTp), and CCB1 (waaC::pGP ΩTp) (kindly provided by Miguel Valvano).
However, there is one risk factor that has been suggested to be of particular importance and that is previous episodes of LBP [ 52] and this is also true for PLBP and/or PGP [ 1, 2, 53].
Virtually all PGP 9.5 positive fibers expressed 5-HT3A receptors.
Deoxycholic acid derivatives were designed as P-glycoprotein (Pgp, ABCB1) inhibitors.
There is an evidence on modulation of M6G entry into brain by membrane P-glycoprotein (Pgp) [33, 34, 35].
The vast majority of the PGP 9.5 positive fibers expressed 5-HT3A receptors.
12.0% of the PGP 9.5 positive fibers were found to co-express NaV1.8 and 5-HT3A receptors.
Most fibers that showed PGP 9.5 immunoreactivity were associated with myocytes (masseter = 68.4%, tibialis = 87.8%).
The fibers shown are positively labelled for PGP 9.5 (A), 5-HT3A(B), and NaV1.8 (C).
The small cells expressed CD56 (7/8), neuron-specific enolase (7/8), synaptophysin (3/8), PGP 9.5 (3/8), and chromogranin A (2/8).
For four data sets (MUSK2 [41] 41], QSAR [42, 43], BBB [44], PGP [45]) the previously published descriptors were used.
